ARS Pharmaceuticals, Inc. SPRY
3.05 USD 0.00 (+0.00%)
At closeNov 4, 2026, 4:00 PM EST
3.11 +0.06 +1.97%
After hours · Nov 4, 4:00 PM ET
3.00 Day range 3.23
2.91 52-week range 13.15
- YTD
- -73.82%
- 1 year
- -64.98%
Financial health
Altman Z-Score
-3.17 Distress zone
Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.
Piotroski F-Score
2 / 9 Weak
Nine pass/fail tests of profitability, leverage and efficiency.
FMP rating
D+1 / 5 overall
- DCF 1
- Return on Equity 1
- Return on Assets 1
- Debt / Equity 1
- P/E 1
- P/B 1
Valuation
P/E -6.7×
FY 2018 5y median -9.5× FY 2025
P/S 13.6×
FY 2018 5y median 34.9× FY 2025
P/B 10.1×
FY 2018 5y median 2.3× FY 2025
P/FCF -6.7×
FY 2018 5y median -8.5× FY 2025
EV/EBITDA -7.2×
FY 2018 5y median -7.1× FY 2025
EV/Sales 14.3×
FY 2018 5y median 25.7× FY 2025
FCF Yield -14.9%
FY 2018 5y median -11.4% FY 2025
Profitability
Gross Margin 75.8%
FY 2018 5y median 76.9% FY 2025
Operating Margin -212.9%
FY 2018 5y median -353.3% FY 2025
Net Margin -203.3%
FY 2018 5y median -367.7% FY 2025
ROE -149.9%
FY 2018 5y median -12.7% FY 2025
ROIC -62.2%
FY 2018 5y median -29.2% FY 2025
ROA -52.3%
FY 2018 5y median -23.3% FY 2025
Growth (YoY)
Revenue -5.5%
FY 2018 FY 2025
Operating Income -5720.6%
FY 2018 FY 2025
EPS (diluted) -2327.9%
FY 2018 FY 2025
Free Cash Flow -1418.5%
FY 2018 FY 2025
Financial Health
Current Ratio 7.3×
FY 2018 5y median 14.3× FY 2025
Quick Ratio 7.1×
FY 2018 5y median 14.0× FY 2025
Debt / Equity 0.8×
FY 2018 5y median 0.0× FY 2025
Net Debt / EBITDA -0.3×
FY 2018 5y median 1.3× FY 2025
Interest Coverage -69.0×
FY 2018 5y median 0.0× FY 2025
Dividends
Dividend Yield 0.0%
FY 2018 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2018 5y median 0.0% FY 2025
Annual · latest fiscal year ends 2025-12-31
